Osaic Holdings’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66K | Sell |
882
-32
| -4% | -$60 | ﹤0.01% | 6544 |
|
|
2025
Q1 | $1.48K | Sell |
914
-2,609
| -74% | -$4.24K | ﹤0.01% | 6560 |
|
|
2024
Q4 | $6.44K | Buy |
3,523
+600
| +21% | +$1.1K | ﹤0.01% | 5968 |
|
|
2024
Q3 | $16.9K | Buy |
2,923
+157
| +6% | +$907 | ﹤0.01% | 5428 |
|
|
2024
Q2 | $22.3K | Sell |
2,766
-2,716
| -50% | -$21.9K | ﹤0.01% | 5229 |
|
|
2024
Q1 | $76.1K | Buy |
5,482
+1,093
| +25% | +$15.2K | ﹤0.01% | 4429 |
|
|
2023
Q4 | $26.9K | Sell |
4,389
-3,461
| -44% | -$21.2K | ﹤0.01% | 5313 |
|
|
2023
Q3 | $36.6K | Sell |
7,850
-21,498
| -73% | -$100K | ﹤0.01% | 5189 |
|
|
2023
Q2 | $158K | Buy |
29,348
+12,306
| +72% | +$66.2K | ﹤0.01% | 4085 |
|
|
2023
Q1 | $167K | Buy |
17,042
+3,636
| +27% | +$35.6K | ﹤0.01% | 4011 |
|
|
2022
Q4 | $251K | Sell |
13,406
-834
| -6% | -$15.6K | ﹤0.01% | 3658 |
|
|
2022
Q3 | $294K | Sell |
14,240
-717
| -5% | -$14.8K | ﹤0.01% | 3399 |
|
|
2022
Q2 | $311K | Buy |
14,957
+1,854
| +14% | +$38.6K | ﹤0.01% | 3393 |
|
|
2022
Q1 | $627K | Buy |
13,103
+1,988
| +18% | +$95.1K | ﹤0.01% | 3006 |
|
|
2021
Q4 | $668K | Sell |
11,115
-5,220
| -32% | -$314K | ﹤0.01% | 2780 |
|
|
2021
Q3 | $1.4M | Buy |
16,335
+3,412
| +26% | +$293K | ﹤0.01% | 2040 |
|
|
2021
Q2 | $1.44M | Buy |
12,923
+1,014
| +9% | +$113K | ﹤0.01% | 2012 |
|
|
2021
Q1 | $1.33M | Sell |
11,909
-296
| -2% | -$33K | ﹤0.01% | 1976 |
|
|
2020
Q4 | $1.3M | Sell |
12,205
-5,879
| -33% | -$625K | ﹤0.01% | 1804 |
|
|
2020
Q3 | $2.59M | Buy |
18,084
+6,844
| +61% | +$980K | 0.01% | 1160 |
|
|
2020
Q2 | $3.64M | Buy |
11,240
+6,606
| +143% | +$2.14M | 0.01% | 866 |
|
|
2020
Q1 | $419K | Buy |
+4,634
| New | +$419K | ﹤0.01% | 2244 |
|